Apyx Medical Corporation logo

Apyx Medical Corporation

APYX

NASDAQHealthcareMedical - Specialties

Previous close

$3.12

+$0.09 · +2.97%

Aug 21, 4:00 PM ET

APYX company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

75

Undervalued

Momentum

53

Neutral

Sentiment

49

Mixed

Risk resilience

43

Elevated Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company’s helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Industry
Medical - Specialties
Sector
Healthcare
Headquarters
US
CEO
Charles D. Goodwin
Listed since
Jan 2, 2019
Employees
205

Market position

Day range

Current $3.12

52-week range

Current $3.12

Open
$3.06
Previous close
$3.03
Volume
52.89K
0.35× average
Average volume
149.59K
Average daily volume
Market cap
131.38M USD
Beta
1.35
Market reference 1
50-day average
$4.0034
-22.07% below average
200-day average
$3.8512
-18.99% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

P/E (TTM)
-15.09×
P/B (TTM)
12.34×
P/S (TTM)
2.25×
Dividend yield
0.00%

Profitability & efficiency

Gross margin
33.94%
Operating margin
-6.06%
Net margin
-14.78%

Financial health

Debt / equity
3.72×
Altman Z-score
1.1
Piotroski F-score
3 of 9

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Rating distribution

9 ratings
Strong buy00%
Buy889%
Hold111%
Sell00%
Strong sell00%

APYX peers

ETFs holding APYX

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research APYX

research.disclaimer